Mersana Therapeutics, Inc. Assets, Fair Value Disclosure
Mersana Therapeutics, Inc. had Assets, Fair Value Disclosure of $0 as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2019-05-09
- 2019-03-31: Assets, Fair Value Disclosure $0.00.
- 2017-09-30: Assets, Fair Value Disclosure $136.86M.
- 2017-06-30: Assets, Fair Value Disclosure $77.23M.
- 2016-12-31: Assets, Fair Value Disclosure $100.30M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2017-09-30 | $136.86M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $77.23M 10-Q · filed 2017-08-11 |
| 2016-12-31 | $100.30M 10-Q · filed 2017-11-13 |